Abstract:Background Aging is an important risk factor for atherosclerosis and persists as an independent contributor when all other known factors are controlled. Circulating free mitochondrial DNA (cf-mtDNA) can activate immune cells, including monocytes, that promote plaque formation and produce proinflammatory cytokines [1]. Several receptors, including TLR9, AIM2, NLRP3, cGAS can bind cf-mtDNA and activate downstream pathways, leading to the activation of proinflammatory genes [2]. We previously showed that mtDNA increases with age, and at the highest concentrations observed in plasma, can enhance the pro-inflammatory effect of bacterial PAMPs [3]. Nevertheless, it is unknown if the pathways triggered by mtDNA are functionally preserved in elderly, and if it can synergize with oxidized low-density lipoproteins (ox-LDL), which are known to interact with TLR4 and TLR2, in concert with scavenger receptors to regulate the inflammatory microenvironment in atherosclerosis. Purpose This study aims to understand if and how the cf-mtDNA activates monocytes triggering an inflammatory response, if monocyte from young and old donors present a different response to mtDNA if age-related difference in the functional activity of these cells. Methods We selected 10 old subjects (74.4 ± 2.4 y.o.; 2M:8F) without a history of cardiovascular or peripheral arterial diseases, 4 ultranonagenarians (98.3 ± 4.7 y.o.; 1M:3F) and 9 sex-matched young controls (28.4 ± 7.3 y.o.; 0M:9F). Monocytes were isolated from blood samples, and inflammatory response to mtDNA alone or in combination with LPS was assessed, by analyzing TLR9 expression, NF-kB activation and the release in the supernatants of a panel of proinflammatory cytokines. Results Monocyte expression of the mtDNA receptor TLR9 showed a slight reduction with aging, and is similar in old subjects and ultranonagenarians. mtDNA was internalized only in cells pre-treated with LPS and co-localized with TLR9. When internalization occurred, monocytes treated with mtDNA+LPS, released pro-inflammatory cytokines at higher levels than cells treated with LPS alone. Monocytes from elderly subjects showed a partial impairment in mtDNA uptake, and a lower capability to activate TLR9 downstream pathway. However, the capability to secrete pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) was not compromised, and NF-kB translocation into the nucleus after treatment with mtDNA is preserved, suggesting that compensatory mechanisms allowed mtDNA-driven activation of monocytes in elderly people. Conclusions The capability of mtDNA to promote an inflammatory response is preserved in elderly people and is still present in ultranonagenarians subjects. As mtDNA plasma levels increase with aging, mtDNA likely act as proinflammatory agents in aged people and can contribute to maintain inflammation in the atherosclerotic plaques. Further studies will clarify if mtDNA can act synergistically with ox-LDL to promote monocyte activation.

Results Suppression of Myeloid Cell mitoOS Protects Against Atherosclerosis and Reduces Myeloid Cell Accumulation in Aged Mice

Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Monocyte response to mitochondrial DAMPs in elderly subjects: a possible contribution to chronic inflammation and atherosclerosis

Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging

Abstract 285: Oxidized Low Density Lipoprotein and Angiotensin II Causes Vascular Senescence Via AT1R Signal-mediate Mitochondrial Fission

Abstract 198: Metabolic Stress Causes Mitochondrial Dysfunction and Vascular Senescence via Angiotensin II Type I Receptor Signal / Rho Kinase Induced Mitochondrial Fission

Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis

Inhibition of Mitochondrial Activity Ameliorates Atherosclerosis in ApoE-/- Mice Via Suppressing Vascular Smooth Cell Activation and Macrophage Foam Cell Formation.

Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis

Macrophage-specific deletion of MIC26 (APOO) mitigates advanced atherosclerosis by increasing efferocytosis

Abstract Tu014: Endoplasmic reticulum stress exacerbates atherosclerosis via microRNA-181a by inhibiting mitophagy

Cellular defense against oxidized low density lipoproteins and fibrillar amyloid beta in murine cells of monocyte origin with possible susceptibility to the oxidative stress induction

Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.

Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging 1

Mitochondrial ALDH2 Deficiency Promotes Fibrosis and ROS Formation in the Myocardium of Aged Mice

Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence

Abstract P141: Aging in Mice Enhances Microvascular Reactive Oxygen Species (ROS) That Impair the Anti-Contractile Actions of Perivascular Adipose Tissue (PVAT)

APN deficiency accelerates brain aging via mitochondrial associated neuroinflammation

Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging

Mitochondrial ALDH2 deficiency promotes fibrosis and reactive oxygen species formation in the myocardium of aged mice